熱門資訊> 正文
Catheter Precision获得高达8800万美元的战略融资
2026-03-11 20:42
- Catheter Precision (VTAK) said it has secured up to $88M in strategic institutional financing commitments to fund accelerated growth.
- The financing provides capital to fund the company’s medical device operations and support the expansion of its newly acquired Flyte aviation platform.
- Catheter Precision (VTAK) on Tuesday completed the acquisition of the remaining 80.02% equity interest in Fly Flyte from Creatd (CRTDD), resulting in 100% ownership of the AI-enabled regional aviation operator.
- VTAK shares fell -9.8% premarket.
More on Catheter Precision
- Creatd sells remaining stake in Fly Flyte to Catheter Precision for about $12 mln in cash and equity
- Financial information for Catheter Precision
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。